Additionally, we detected a negative association between MECOM mRNA and miR-22 expression and a positive association between miR-22 and PU.1 expression in AML patients, which suggests that PU.1-miR-22-MECOM regulation is involved in AML development. Here, SPI1 is linked to acute myeloid leukemia.